From 1 antibody to 3: the #bNAb field is moving toward combination approaches designed to provide broader, long-acting protection against #HIV.
Huub Gelderblom of #HVTN takes us through the pipeline.
We’re live for the next 40 minutes, join us: avac.org/event/whats-...
